Dr Stephen Alexander Irwin, MD in Rogers, AR - Medicare

Dr Stephen Alexander Irwin, MD is a medicare enrolled "Pain Medicine - Pain Medicine" physician in Rogers, Arkansas. His current practice location is 5302 W Village Pkwy, Ste 1, Rogers, Arkansas. You can reach out to his office (for appointments etc.) via phone at (479) 268-6090.

Dr Stephen Alexander Irwin is licensed to practice in Arkansas (license number E-6777) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1699954172.

Contact Information

	Dr Stephen Alexander Irwin, MD
	5302 W Village Pkwy, Ste 1, Rogers, AR 72758
	(479) 268-6090
	(479) 268-6099

Physician's Profile

Full Name	Dr Stephen Alexander Irwin
Gender	Male
Speciality
Experience	Years
Location	5302 W Village Pkwy, Rogers, Arkansas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Stephen Alexander Irwin attended and graduated from in

NPI Data:

NPI Number: 1699954172
Provider Enumeration Date: 10/31/2007
Last Update Date: 08/20/2021

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Stephen Alexander Irwin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1699954172	NPI	-	NPPES
E-6777	Other	AR	MEDICAL LICENSE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0014X	Pain Medicine - Interventional Pain Medicine	E-6777 (Arkansas)	Secondary
208VP0000X	Pain Medicine - Pain Medicine	E-6777 (Arkansas)	Primary
207L00000X	Anesthesiology	E-6777 (Arkansas)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Stephen Alexander Irwin is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Stephen Alexander Irwin, MD Po Box 15987, Belfast, ME 04915-4054 Ph: (972) 792-5700	Dr Stephen Alexander Irwin, MD 5302 W Village Pkwy, Ste 1, Rogers, AR 72758 Ph: (479) 268-6090

News Archive

Updated My MS Manager mobile phone app helps individuals with MS better manage their disease

My MS Manager, the first-of-its kind mobile phone app created by the Multiple Sclerosis Association of America to help individuals with multiple sclerosis (MS) better manage their disease, now offers new features including a way to connect and share information with one's physician.

Asthmatics to suffer more this winter warn experts

Asthma sufferers in Australia have been warned about a bad cold and flu season ahead. 58 percent of the susceptible population is already experiencing asthma attacks since the start of the season according to The National Asthma Council Australia (NACA) on Monday. They went on to say that nearly half of this population is still not vaccinated against seasonal flu.

Bush Administration directive to enroll low-income children in SCHIP before expanding coverage is unenforceable because it violates Federal law, according to GAO

The Bush administration violated federal law last year when it issued a policy directive that restricts states' ability to expand their SCHIP programs, according to a Government Accountability Office legal opinion released Friday, the New York Times reports (Pear, New York Times, 4/19).

GenCell Biosystems acquired by Becton, Dickinson and Company

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.

Different neurobiological pathways lead to expression of Alzheimer's disease

The amyloid cascade hypothesis of Alzheimer's disease (AD) posits that sticky aggregations or plaques of amyloid-beta peptides accumulate over time in the brain, triggering a series of events that ultimately result in the full-blown neurodegenerative disorder. The hypothesis has been a major driver of AD research for more than 20 years.

Dr Stephen Alexander Irwin, MD - Medicare in Rogers, AR